Alimta FDA Approval History
FDA Approved: Yes (First approved February 4, 2004)
Brand name: Alimta
Generic name: pemetrexed
Dosage form: Injection
Company: Eli Lilly
Treatment for: Malignant Pleural Mesothelioma, Non-Small Cell Lung Cancer
Alimta (pemetrexed) is an antifolate antineoplastic agent indicated for the treatment of malignant pleural mesothelioma and locally-advanced and metastatic non-small cell lung cancer (NSCLC).
Development Timeline for Alimta
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.